Trials commence at Papworth for lung isolation device

NHS Innovations East was set up to help NHS staff in the region develop new ideas that will enhance healthcare delivery. One of the latest innovations to emerge is a new device designed to improve patient safety in lung isolation for thoracic surgery.

Clinical trials have now commenced at Papworth Hospital and an exclusive deal has been signed with Phoenix Medical, a P3 Medical company, for the commercial rights to the “Papworth BiVent Endotracheal tube”.

Compared to other techniques, positioning within the appropriate bronchus is claimed to be easier and less time consuming. More importantly, the bifurcated tip design stabilises the inflated “blocker cuff” (the device that isolates the lung), preventing herniation into the trachea or dislodgement from the bronchial orifice. This reduces the risk of displacement when moving the patient, or during surgical handling of the lungs, thereby improving patient safety.

Latest Issues

EBME Expo 2026

Coventry Building Society Arena, Coventry
24th – 25th June 2026

AfPP Regional Conferences: Manchester

INNSiDE by Meliá Manchester
20th June 2026

Endoscopic Anterior Skull Base Surgery: Hands-On Cadaveric Course

Division of Anatomy, University of Leeds
29th- 30th June 2026

BLOCKED – Advanced+ | The Wrightington Regional Anaesthesia Interest Group Cadaveric Course

Wrightington Conference Centre
Tuesday 7th – Wednesday 8th July 2026

AESCULAP ACADEMY LIVE - Circular Economy in Action

B. Braun Business Centre, Sheffield
Friday 10th July 2026

AfPP Regional Conferences: Bristol

BAWA Leisure
18th July 2026